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Abstract 37 
 Background: Normobaric hypoxic conditioning (HC) is defined as exposure to 38 
systemic and/or local hypoxia at rest (passive) or combined with exercise training (active). 39 
HC has been previously used by healthy and athletic populations to enhance their physical 40 
capacity, and improve performance in the lead up to competition. Recently, HC has also been 41 
applied acutely (single exposure) and chronically (repeated exposure over several weeks) to 42 
overweight and obese populations with the intention of managing and potentially increasing 43 
cardio-metabolic health and weight loss. At present, it is unclear what the cardio-metabolic 44 
health and weight loss responses of obese populations are in response to passive and active 45 
HC. Exploration of potential benefits of exposure to both passive and active HC may 46 
provide pivotal findings for improving health and well being in these individuals. 47 
Methodology: A systematic literature search for articles published between 2000 and 48 
2017 was carried out. Studies investigating the effects of normobaric HC as a novel 49 
therapeutic approach to elicit improvements in the cardio-metabolic health and weight loss of 50 
obese populations were included.  51 
  Results: Studies investigated passive (n = 7; 5  animal, 2  human), active (n = 4; all  52 
human) and a combination of passive and active (n = 4; 3  animal, 1  human) HC to an 53 
inspired oxygen fraction (FiO2) between 4.8–15.0%, ranging between a single session and 54 
daily sessions per week, lasting from 5 days up to 8 months. Passive HC led to reduced 55 
insulin concentrations (-37 – +22%) in obese animals and increased energy expenditure 56 
(+12 – +16%) in obese humans, while active HC lead to reductions in body weight (-4 – -57 
2%) in obese animals and humans, and blood pressure (-8 – -3%) in obese humans, 58 
compared to a matched workload in normoxic conditions. Inconclusive findings, 59 
however, exist in determining the impact of acute and chronic HC on markers such as 60 
triglycerides, cholesterol levels and fitness capacity. Importantly, most of the studies that 61 
included animal models involved exposure to severe levels of hypoxia (FiO2 = 5.0%; 62 
simulated altitude >10,000 m) that are not suitable for human populations.  63 
 Conclusions: Overall, normobaric HC demonstrated observable positive findings in 64 
relation to insulin and energy expenditure (passive), and body weight and blood pressure 65 
(active), which may improve the cardio-metabolic health and body weight management of 66 
obese populations. However, further evidence on responses of circulating biomarkers to both 67 
passive and active HC in humans is warranted.  68 
 69 
Word count: 391 70 
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1. Introduction 71 
Obesity has been labeled as the global epidemic of the 21
st
 century (78). In the United 72 
Kingdom alone, 58% of women and 65% of men are considered to be overweight or obese, 73 
i.e., defined as having a body mass index (BMI) of 25–29.9 or ≥30 kg.m2, respectively (49). 74 
Compared to the early 1990s, whereby obesity prevalence was estimated to be ~15%, those 75 
living in today’s society have a 1 in 4 chance of becoming obese (49). Further, co-morbidities 76 
such as cardiovascular disease, type II diabetes and cancer are at  greater risk of development 77 
in obese popuations resulting in the possibility of higher mortality rates (21).  78 
 Obesity is typically caused by a consistently positive energy balance, i.e., greater 79 
calories consumed versus those expended, which eventually leads to excess fat accumulation 80 
(28) – the negative impact of which is profound in terms of health consequences. Carrying 81 
additional weight can result in elevated blood pressure (7), metabolic deficiencies (28) and 82 
mechanical complications (11) amongst other factors – all of which create an increased 83 
functional demand on the body of obese individuals. Further, the increased mechanical 84 
demand during weight-bearing activities of obese populations may be deleterious on lower 85 
limb joints (i.e., knee and ankle) and limit the functional capabilities compared to healthy and 86 
normal weight populations (70). Aside from bariatric surgery, that is primarily available 87 
for the most severe cases (BMI ≥40 kg.m2 [3]), various interventions including diet 88 
manipulation, caloric restriction, and increased physical activity and exercise (12), are 89 
proposed to counteract these problems. 90 
 For weight loss to be considered clinically significant, a change of ≥3% in body 91 
weight is required (12) – and then ≤3% change to be deemed as weight maintenance over the 92 
duration of several months (65). Typically, weight loss is achieved in the first six months of 93 
commencing a new diet and/or exercise programme, but a plateau is then reached and often 94 
the weight lost is subsequently regained (66). Given the inadequacy of current weight 95 
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management strategies, innovative approaches are warranted for clinically-relevant weight 96 
loss treatment and significant improvements in the health and general well-being of those 97 
who are overweight and obese beyond what is achieved to date. 98 
Hypoxia is defined as a reduced (or insufficient) oxygen (O2) supply to tissues caused 99 
by decreases in O2 saturation of arterial blood (24). Hypoxic conditioning (HC) relates to 100 
passive (i.e., during rest) or active (i.e., during exercise) exposure to systemic (whole body) 101 
and/or local (tissue) hypoxia, resulting in a decrease in arterial O2 availability (38). HC can 102 
be implemented acutely (single exposure) or chronically (multiple exposures over prolonged 103 
periods of time). Permenant residence in a hypobaric hypoxic (terrestrial altitude due to 104 
lower-than-sea level barometric pressure) environment has shown to reduce the likleyhood of 105 
becoming obese (68). Several studies have reported weight loss (1, 58, 81), reduced blood 106 
pressure (35, 61) and improved metabolic function (35, 61, 64, 72, 73) after a 1–3 week 107 
residential stay (e.g. hotel and food provided, light entertainment acitivites throughout the 108 
day, no structured exercise program) at terrestrial altitude (1500–8800 m). However, 109 
permanent living or travelling regularly to terrestrial altitude may not be feasible to all (i.e., 110 
re-location, elevated cost, lack of time). In obese populations, this practice could also lead to 111 
side effects such as physiological and metabolic deficiencies (44), including obstructive sleep 112 
apnea (30) or the development of acute mountain sickness (81).  113 
Alternatively, exposure to normobaric hypoxia (or simulated altitude via a reduced 114 
inspired O2 fraction [FiO2]), is increasingly popular as the number of commercially-available 115 
devices permitting simulated hypoxic exposure is growing. Primarily, this intervention allows 116 
living at or near sea level and then exposing, periodically, individuals to hypoxic conditions 117 
at rest or whilst exercising. This is typically accomplished by breathing through a mask 118 
or staying in an environmentally controlled chamber/room/tent whereby the FiO2 is 119 
typically reduced to 15–12% (equivalent to simulated altitudes of ~2600–4300 m). In 120 
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sedentary overweight males, for instance, passive acute (single 3-hour exposure session) 121 
normobaric HC increased energy expenditure and altered fuel utilisation (reduced glucose 122 
and increased lipid oxydation), while further passive HC (multiple 3-h exposure sessions on 7 123 
consecutive days) magnified these metabolic adjustments (77). For a range of exercise 124 
intensities (55–65% of maximal O2 uptake [VO2max] / 60–70% of maximum heart rate 125 
[HRmax]) and similar levels of simulated altitude (~2600 m), other studies (18, 32, 46, 51, 76) 126 
have suggested that active HC induces specific molecular adaptations that do not occur when 127 
training in a normoxic environment (66). These positive adaptations, in particular, include 128 
increased basal noradrenaline levels (4), arteriole diameter and peripheral vasodilation (45), 129 
mitochondria number (66), glycolytic enzyme activity (16), insulin sensitivity (40), as well as 130 
reduced diastolic blood pressure (63) and leptin levels (29). Such physiological adaptations 131 
would in turn improve the metabolic phenotype of obese individuals. 132 
Recent reviews have investigated the impact of O2 availability as a therapeutic 133 
intervention for body weight management (56), intermittent hypoxia for fat loss and 134 
enhancement of cardiovascular health (66), the role of hypoxia in energy balance (28), 135 
hypoxic conditioning for several pathological diseases (67) and the effectiveness of hypoxic 136 
training on cardio-metabolic risk factors (71). Overall, these reviews tend to agree that 137 
both hypoxia and hyperoxia (i.e., environmental conditions posing a challenge to O2 138 
homeostasis) may play a significant role in the processes associated with obesity and 139 
weight loss paradigm. However, the aforementioned reviews are limited in terms of 140 
systematically examining the potential impact of passive and active HC on markers of cardio-141 
metabolic health and well-being (71), while some focus solely on human research with no 142 
consideration of findings from animal models (66, 71). Further, combining the literature on 143 
HC of populations with a multitude of diseases (e.g., cardiovascular and pulmonary) does not 144 
provide conclusive evidence in relation to the specific treatment of obese populations (67). 145 
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Due to the mechanical restrictions and weight loading implications on lower limbs (i.e., on 146 
the knee and ankle joints) when completing exercise in at-risk (obese, overweight and 147 
sedentary) populations (70), the exploration of potential benefits of exposure to both passive 148 
and active HC may provide pivotal findings for weight loss and maintenance strategies.  149 
Therefore, the aim of this systematic review is to a) summarise the current literature 150 
surrounding passive and active normobaric HC as a therapeutic method for improving cardio-151 
metabolic health and managing weight-loss in obese animals and humans, and b) offer 152 
perspectives for future research within this area of literature.  153 
 154 
2. Materials and methods 155 
2.1. Literature search 156 
A literature search was carried out in the Pubmed, ScienceDirect, Scopus, Web of 157 
Science and SportsDiscus databases. The terms (intermittent hypoxia OR passive hypoxic 158 
exposure OR hypoxic training OR altitude training OR live-low train-high) AND 159 
(obesity OR overweight OR weight loss OR physiological response OR metabolic 160 
response OR cardiovascular response) were combined to search the full text of 161 
experimental articles published after 2000 and before January 2017. Each title, abstract 162 
and full text were assessed for relevance to the topic and selected if they met the inclusion 163 
criteria as follows: an original research article; randomised and controlled design; human or 164 
animal experimentation; overweight (BMI: 25–30 kg.m2), obese (BMI: 30–38 kg.m2) and/or 165 
sedentary participants; normobaric hypoxic intervention; assessment of at least one of the 166 
following parameters: blood pressure, glucose concentrations, insulin levels or cholesterol; 167 
English language; and published in a peer-reviewed journal. Exlcusion criteria were: 168 
athletic/sport population/performance focus; involved obstructive sleep apnoea; clinical 169 
studies; implemented hypobaric/no hypoxia; or included a physically active or 170 
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adolescent population. Only full text articles were reviewed. In addition to the literature 171 
search, references were scanned for further relevant articles and were included if they met the 172 
inclusion criteria.  173 
 174 
2.2. Assessment of Methodological Quality 175 
 A modified scale to assess the methodological quality of the studies retrieved in this 176 
review was carried out following selection of full text articles. The modified version was 177 
applied due to the greater representation for experiments employing a training intervention, 178 
compared to the Delphi, PEDro and Cochrane scales (53). A 10 item quality rating guide 179 
included the criteria listed below and guided the assessment scoring of each study as follows: 180 
0 = clearly no; 1 = maybe; 2 = clearly yes; range = 0 (poor)–20 (excellent). 181 
1. Inclusion criteria were clearly stated; 182 
2. Subjects were randomly allocated to groups; 183 
3. Intervention was clearly defined; 184 
4. Groups were tested for similarity at baseline; 185 
5. A control group was used; 186 
6. Outcome variables were clearly defined; 187 
7. Assessments were practically useful; 188 
8. Duration of intervention was practically useful; 189 
9. Between-group statistical analysis was appropriate; 190 
10. Point measures of variability; 191 
 192 
3. Results 193 
3.1. Search results 194 
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Fig. 1 illustrates a flow chart of the search results. The search yielded a total of 212 195 
publications. After removal of irrelevant titles, 23 items remained in relation to the focus of 196 
the review, reduced to eight following abstract assessment, and subsequently four full texts 197 
that met the inclusion criteria. Additionally, a further eleven full text items were added via 198 
reference list searching. 199 
*Fig. 1 near here* 200 
 201 
3.2. Methodological quality assessment 202 
 The average quality of the 15 studies included in this review was 16/20 according to 203 
Paul et al. (53). One study scored 20/20, and the lowest score was 12/20.  204 
 205 
3.3. Study characteristics 206 
Table 1 illustrates the details of the studies included in this review. Eight studies 207 
used animal models (2, 6, 34, 37, 52, 55, 59, 79). Five of these implemented a protocol of 208 
passive HC only (2, 34, 52, 55, 59), two active normoxic periods followed by passive HC 209 
(6, 79), and one used passive and active HC combined (37). All animal studies included 210 
obese rodents (mice or rats) aged between 3 and 24 weeks, seven used male (2, 6, 37, 52, 211 
55, 59, 79) and one involved female (34) models. Five of the animal model groups were 212 
genetically obese (2, 6, 55, 59, 79), while three were fed a high-fat diet (34, 37, 52). Other 213 
than one study stating leptin deficiency in their animal models (34), no other difference 214 
in the health of animals across studies was mentioned. 215 
Seven of the eligible studies investigated human participants (18, 32, 46, 51, 69, 216 
76, 77). Two of these employed passive HC only (69, 77), four active HC only (32, 46, 51, 217 
76), and one investigated both passive and active HC (18). Four of the human 218 
investigations were composed of both males and females (18, 32, 51, 76), with the 219 
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remaining three including males only  (46, 69, 77). Further, four studies used obese 220 
(BMI = 30–37.1 kg.m2 [18, 32, 51, 76]), one overweight  (BMI = 27 kg.m2 [77]) and one 221 
sedentary (normal weight with a BMI = 22.2 kg.m2 [69]) participants. The body 222 
composition of one participant cohort was not reported (46). Participants were aged 223 
between 21–51 years. Where mentioned, participants were free from hypertension (18, 224 
77), diabetes (76), stroke (18), acute and chronic cardio-vascular, pulmonary and 225 
respiratory diseases/infections (18, 69, 76, 77), barriers to physical activity (32), 226 
altitude/hypoxic exposure (32, 76), medication to control weight or metabolism (32, 69, 227 
77), alcohol/drug abuse and smoking (33, 69, 76, 77), and exercise (32, 46, 69, 77) within 228 
≥3 months of enrolling.  229 
*Table 1 near here* 230 
  231 
3.4. Animal studies 232 
3.4.1. Passive hypoxic exposure 233 
The five investigations reviewed implemented two modes of passive HC, namely 234 
intermittent and sustained hypoxia. Intermittent protocols adopted a pattern of 30 s of 235 
exposure to hypoxia followed by 30 s of exposure to normoxia, lasting for 8 h (2) and 12–16 236 
h per day (55). There were modifications to this approach in two of the investigations as 237 
follows: 40 and 80 s of exposure to hypoxia and normoxia, respectively (52), and 2 x 15-min 238 
periods of exposure to hypoxia interspersed with 5 and 10 min of exposure to normoxia (34). 239 
Only Rodriguez et al. (59) implemented a sustained exposure period of 24 h per day. The 240 
hypoxic level ranged between FiO2 = 4.8% (2, 52, 55, 59) and 14.3% (34), while most studies 241 
used a FiO2 of ~5.0% (2, 52, 55, 59) All interventions involved daily exposure. Most studies 242 
examined responses over a prolonged period of time (2–6 weeks [2, 34, 52, 59]), with only 243 
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Polotsky et al. (55) investigating both short-term (5 days) and long-term (12 weeks) 244 
responses.  245 
 246 
3.4.2. Combined passive and active hypoxic exposure 247 
  Chen et al. (6) and Wu et al. (79) implemented a live high-train low (LHTL) 248 
intervention, with 90-min exercise sessions (moderate-intensity swimming) carried out in 249 
normoxia, followed by sustained passive HC periods (8 h per day, FiO2 = 14.0%). Lu et al. 250 
(37) employed a live high-train high (LHTH) intervention, with implementation of 60-min 251 
active HC (moderate-intensity running), and the remaining hours of the day living in the 252 
same hypoxic environment (FiO2 = 13.6%). These interventions ranged  between 4–6 weeks.  253 
 254 
3.5. Human studies 255 
3.5.1. Passive hypoxic exposure 256 
 Wang et al. (69) and Workman & Basset (77) both implemented sustained passive HC 257 
periods corresponding to a period of 60 min and 3 h, respectively. The hypoxic level during 258 
these sessions was controlled via two methods: FiO2 clamped at 12–15% (69), and 259 
manipulation of FiO2 to clamp the arterial O2 saturation (SpO2) at ~80% (77).  260 
 Whereas Wang et al. (69) implemented a 4-week intervention (5 days of exposure per 261 
week, 60-min sessions), Workman & Basset (77) investigated responses to both a single 3-h 262 
session as well as the same period of exposure and hypoxic level on an additional 6 263 
consecutive days. 264 
  265 
3.5.2. Active hypoxic exposure 266 
 Active investigations have used a live low-train high (LLTH) approach and 267 
implemented exercise of a moderate intensity (55–65% VO2max / 60–70% HRmax). Exercise 268 
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programmes were typically cardiovascular-based (running, cycling, stepping [32, 46, 51, 269 
76]), with one study adding strength training (40–50% of 1 repetition maximum, 3 sets of 15 270 
repetitions, interspersed with 2–3-min rest periods [32]). 271 
 The FiO2 in all studies was 15.0%. Typical exercise prescription included sessions of 272 
60–90 min in duration, performed three times per week, over a 4-week period (32, 46, 76), 273 
with one study implementing a longer training period of eight weeks (51). Kong et al. (32) 274 
took their participants to a sea-level residential camp for 4 weeks, which permitted a greater 275 
amount of time for exercise per week (22 h) and dietary control. Although, the hypoxic group 276 
spent only 6 h in hypoxia per week (exercise modality unknown) with the remainder of the 277 
sessions (16 h) carried out in normoxic conditions. 278 
 279 
3.5.3. Combined passive and active  exposure 280 
 Gatterer et al. (18) utilised a combination of passive and active HC via a LLTH 281 
approach over a period of 8 months. Participants completed 90-min moderate intensity (65–282 
70% of HRmax) exercise sessions on an exercise ergometer of their choice (cycle, treadmill, 283 
cross-trainer), immediately followed by 90 mins rest, all in hypoxic (FiO2 = 12–14%) 284 
conditions, twice weekly.  285 
 286 
4. Discussion 287 
4.1. Animal studies 288 
4.1.1. Passive hypoxic exposure 289 
Table 2 presents the overall findings of the animal studies included in this 290 
review. Glucose concentrations are commonly measured in obese animals following passive 291 
HC as an indirect marker of insulin sensitivity, however, the findings of this measure are 292 
inconsistent. Polotsky et al. (55) and Ling et al. (34) both found reductions in fasting glucose 293 
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concentrations following intermittent HC, despite exposure time/cycle (30 s :30 s versus 15 294 
min :5–10 min, respectively) and severity of hypoxic exposure (FiO2 = ~5.0% versus 14.3%, 295 
respectively) being largely different between protocols. In contrast, Briancon-Marjollet et al. 296 
(2) reported significant glucose concentration increases in obese rats after 8 h of intermittent 297 
(30 s :30 s) HC to an extreme hypoxic level (FiO2 = 5.0%) per day over 2 weeks. Other 298 
investigations have shown unchanged values when animals were exposed intermittently to 299 
similar hypoxic levels using protocols of 40 s :80 s for 8 h (52) and 30 s :30 s for 12 h (55) 300 
per day. It seems that the common response of glucose concentrations in obese animals, 301 
passively exposed to varying levels of hypoxia, is yet to be verified. This variation in the 302 
present findings may be partly explained through the differences in pre-analytical 303 
conditions of sampled tissue, which was subsequently utilised for glucose concentration 304 
assessment (84).  305 
Insulin is receiving a great deal of attention due to its dominance in Type II Diabetes 306 
control and development (26). In obese rats, insulin concentrations were unchanged 307 
following intermittent HC for 8 h per day (40 s :80 s [52]; and 30 s :30 s [2]). This is perhaps 308 
due to the severity of the hypoxic stimulus (FiO2 = ~5.0%) blunting improvements in this 309 
health marker (50). Only one study has reported significant increases in insulin levels, which 310 
occurred following both a 5 day (+356%) and 12 week (+185%) hypoxic intervention in 311 
obese mice (55). The highly significant increase in insulin concentrations shown here may 312 
not actually be of benefit. Perhaps, exacerbation of insulin resistance occurred, leading to 313 
hyperinsulinemia (79). It is interesting to note that the hypoxic level employed in these 314 
studies was similar (FiO2 = ~5.0%), and animals were intermittently exposed to hypoxia over 315 
1 :1 (30 s :30 s) and 1 :2 (40 s :80 s) sequences. Reducing the severity of hypoxia during 316 
exposure periods may prevent dramatic increases, as reported here by Polotsky et al. (55), 317 
13 
 
and protect against subsequent exacerbation and development of hyperinsulinemia. This 318 
assumption, however, needs to be verified in an obese human population. 319 
Varying findings of cholesterol following HC have been reported. Reductions in total 320 
cholesterol were found following hypoxic exposure (15 min :5–10 min, 8 times per day for 321 
40 days, FiO2 = 14.3%) in both lean and obese mice (34). Contrastingly, an increase in total 322 
cholesterol values occured following HC (40 s :80 s for 8 h per day over 14 days, FiO2 = 323 
5.0%) in obese rats, and in control (no hypoxic exposure) lean and obese rats (52). In another 324 
study, no difference was reported in both lean and obese animals exposed to hypoxia (30 s 325 
:30 s for 8 h per day over 14 days, FiO2 = 5.0%) or those who received no hypoxic exposure 326 
(2). Although the variance is apparent, it is difficult to interpret findings due to there being a 327 
lack of individual evaluation of levels of high-density (HDL) and low-density (LPL) 328 
lipoprotein. Increases in total cholesterol in response to HC may in fact be a result of an 329 
increase in the HDL/LDL ratio, which would actually be beneficial but is not yet clear in the 330 
current literature.  331 
Leptin, a satiety hormone, is suggested to be associated with weight loss due to its 332 
action on hypothalamic metabolism and appetite suppression, potentiating a reduced energy 333 
intake (47). It is also considered a growing marker of weight loss during and following HC 334 
(50). Studies have reported increases in leptin in both hypoxic and normoxic groups (2, 52), 335 
but there was no assessment of body weight changes. Increases in serum leptin have been 336 
found following intermittent, moderate hypoxic and normoxic exposure of 15 min :5–10 min, 337 
respectively, compared to those who received no exposure to hypoxia (34), which was also 338 
aligned with slower rates of weight gain (+79% versus +100%, respectively). Notably, the 339 
animal models were fed a high-fat diet during the course of the intervention, which therefore 340 
may explain the reports of weight gain in this study. It could be that the weight gain was a 341 
result of increases in muscle mass of the animal models, but this measure was not assessed. 342 
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In summary, a small amount of evidence suggests that leptin may be a marker 343 
associated with weight loss, due to the findings of slower weight gain following passive 344 
HC.  345 
Triglycerides, an important part of fat storage (13), have been found to increase 346 
following intermittent (40 s :80 s) HC for 8 h per day over 2 weeks in obese rats (+30% [52]). 347 
Notwithstanding, equal changes occurred in the control group (+30%), whom didn’t received 348 
any hypoxic treatment. In addition to this, mean arterial blood pressure increased  similarly in 349 
both groups. This may have been a result of the investigators feeding animals a high-fat diet 350 
alongside the hypoxic intervention, and subsequently blunting the potentially beneficial 351 
effects. These findings further highlight the co-morbidity relationship between obesity and 352 
hypertension whilst consuming a high-fat diet, which will not be reduced with severe hypoxic 353 
levels as shown in other studies (2, 52).  354 
Finally, only three studies have measured body weight before and after a chronic 355 
passive hypoxic intervention in obese animals. Ling et al. (34) found weight to increase 356 
equally in the hypoxic group (+79%) and the control group (+78%). Rodriguez et al. (59) 357 
reported weight to increase in the hypoxia group (+9%) but with slightly greater increases in 358 
the control group (+13%). Previously, weight loss has generally been observed in the first 359 
days of exposure (41, 42). However, this has not been the case in the present review. 360 
Finally, Polotsky et al. (55) reported no change in any group. The discrepancy in findings of 361 
body weight following passive HC presented here may be due to a lack of dietary control. 362 
From an experimental perspective, controlling caloric intake may be difficult in animal 363 
models and subsequently leads to disparate changes in weight (i.e., weight gain). Only 364 
Polotsky et al. (55) stated what the animal models were fed throughout the intervention and 365 
reported no change in body weight. The majority of available studies presented here 366 
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actually report weight gain after repeated passive HC over 4–12 weeks. To summarise, 367 
passive HC in obese animals, fed a high-fat diet, does not lead to conclusive weight loss. 368 
*Table 2 near here* 369 
 370 
4.1.2. Combined passive and active hypoxic exposure 371 
 Unlike passive HC alone, reductions in fasting glucose and insulin responses have 372 
typically been found following a combination of passive HC and normoxic active periods (6, 373 
79). Interestingly, the hypoxic level (FiO2 = ~14.0%) as well as the duration and mode of 374 
exercise employed (1.5 h of swimming) was similar across studies. Notably, Wu et al. (79) 375 
also found reductions in fasting glucose concentrations within the group whom carried out 376 
normoxic exercise without passive HC. This raises questions as to whether exercise alone is 377 
more effective than a combination of exposure modes. Passive HC and normoxic active 378 
periods, when combined, could potentially improve metabolic and hormonal responses 379 
of obese animals. Pending confirmatory research, this could at least in part be ascribed to 380 
improved insulin sensitivity and cellular glucose uptake. 381 
 The primary question regarding the use of passive and active HC is whether it leads to 382 
more benefical health outcomes than a similar workload completed in normoxic conditions. 383 
Lu et al. (37) concluded that, compared to a control group, who received no exposure to 384 
hypoxia or exercise completion, obese rats lost significant amounts of weight, fat mass, LDL 385 
and total cholesterol after a combination of 60-min running sessions in hypoxic conditions 386 
(FiO2 = 13.6%) and permenant residence in the same hypoxic environment, conducted over 4 387 
weeks. Therefore, perhaps the increased physical workload, regardless of the conditions the 388 
animal models were in, led to improvements in cardio-metabolic health and reductions in 389 
weight. Notably, HDL cholesterol was reduced in the hypoxic group (37), presenting a 390 
negative effect of active hypoxic exposure, as HDL cholesterol is deemed as ‘good’ 391 
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cholesterol (17). The change in HDL levels may be a reflection in the overall reduction in 392 
total cholesterol. Therefore, this may have led to a reduction in HDL and LDL, but with the 393 
maintenance of relative concentrations and HDL:LDL ratio. 394 
 The remaining two combined normoxic active periods and passive HC studies 395 
included in this review, which measured weight pre- and post-intervention, reported similar 396 
findings. Both Chen et al. (6) and Wu et al. (79) implemented identical protocols consisting 397 
of daily 90-min swimming sessions in normoxic conditions followed by passive HC (FiO2 = 398 
14.0%, sustained for 8-h per day). Both studies found greater body weight attenuation of the 399 
obese animal models, in comparison to the increase in the control group (no passive and 400 
active exposure). Further, weight did not change in the group who completed exercise in 401 
normoxic conditions without passive HC (6, 79). These findings suggest that a combination 402 
of passive and active HC is possibly more beneficial for weight control than a matched 403 
workload in normoxia. To date, however, the mechanisms that induce this response remain 404 
unclear (28). Possible increases in daily metabolic rate of only those in the hypoxic groups, 405 
causing a negative energy balance, may have occurred. Or perhaps appetite was surpressed 406 
through increased leptin concentrations, resulting in a reduced calorie intake. However, 407 
neither of these reponses were assessed in these investigations. 408 
 409 
4.2. Human studies 410 
4.2.1. Passive hypoxic exposure 411 
Table 3 presents the overall findings of the human studies included in this 412 
review. Only two studies included in this review have implemented passive HC in humans. 413 
Blood pressure remained unchanged following acute (single 3-h session) and short-term (3-h 414 
session per day for 7 days) exposure to a SpO2 of ~80% (77). Additionally, unchanged body 415 
weights occurred following daily HC (1 h) for 4 weeks to severe (FiO2 = 12.0%) and 416 
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moderate (FiO2 = 15.0%) hypoxia (69). However, the participants included in these studies 417 
had a healthy BMI (22–27 kg.m2), yet deemed as sedentary, which may explain the 418 
ineffective treatment on blood pressure and body weight. Moreover, it could be suggested 419 
that the participant cohort in these studies (69, 77) required a more severe level of hypoxia to 420 
elicit positive responses. In support of this, recent reviews (50, 67) have indicated a linear 421 
continuum between no additive effect and a deleterious effect with HC that is dependent on 422 
the severity of the hypoxic stimulus. Therefore, previously employed passive HC protocols in 423 
humans may not be beneficial to improve cardio-metabolic health (reduce blood pressure) or 424 
lose weight. 425 
In their study, Workman & Basset (77) assessed metabolic responses, via a 30-min 426 
metabolic rate determination test pre- and post-intervention. They found increases in energy 427 
expenditure following acute (+16%) and short-term (+12%) HC, as did lipid metabolism 428 
(+44% and +29%, respectively); whereas, glycogen metabolism decreased (-31% and -49%, 429 
respectively). Collectively, these findings suggest that passive HC may be an effective 430 
modality to induce a shift in fuel utilisation and expend a greater quantity of lipid-based 431 
energy stores. Over a longer duration, this may lead to a substantially consistent negative 432 
energy balance which may promote measurable weight loss. To date, such a protocol has not 433 
been employed in an obese human population.  434 
*Table 3 near here* 435 
 436 
4.2.2. Active hypoxic exposure 437 
 Metabolic responses have been assessed following active HC (60–90-min moderate-438 
intensity cardiovascular activity, 3 sessions per week, 4–6 weeks, FiO2 = 15.0%) in obese 439 
humans. Netzer et al. (51) reported greater enhancements in triglycerides, total cholesterol 440 
and HDL in those whom completed 8 weeks training for 90-min at 60% of HRmax in hypoxic 441 
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versus normoxic conditions. In other studies, no change has been found in both the hypoxic 442 
and normoxic groups for triglycerides, total cholesterol and HDL following a similar exercise 443 
intensity range and duration over 4 weeks (46, 76). Morishima et al. (46) also reported that 444 
glucose concentrations decreased in both the hypoxic (-8%) and normoxic (-7%) group over 445 
the course of the intervention. These findings are interesting as all intervention groups 446 
exercised under the same hypoxic level and completed the same type of exercise at an 447 
‘absolute’ intensity, i.e. an intensity regardless of the environmental condition. Consequently, 448 
differences in findings may have been related primarily to the total duration of the studies (8 449 
[51] versus 4 weeks [46, 76]). Therefore, it appears that further improvements in metabolic 450 
markers such as triglycerides, total cholesterol and HDL with HC would require an 451 
intervention of more than 4 weeks in duration for positive effects.  452 
 In two studies, fasting insulin reductions have been found in both hypoxic (FiO2 = 453 
15.0%) and normoxic exercise (60 mins, moderate intensity, 3 times per week, for 4 weeks) 454 
groups over the course of an intervention (hypoxia: -37%, normoxia: -33% [76]; hypoxia: -455 
22%, normoxia: -36% [46]). Although not significant, baseline assessment in both studies of 456 
insulin concentrations were ~2 arbitary units larger in the hypoxic compared to normoxic 457 
group. Therefore, this may explain the insignificant effect of the hypoxic stimulus as those in 458 
the control group started the intervention at a lower concentration. Additional consideration 459 
of other hormonal markers, such as growth horomone and insulin-like growth factor, that 460 
may further lead to enhancements of potential weight loss through promotion of mechanistic 461 
responses (60) warrant further investigation. 462 
Hypertension is extremely prevelant in obese populations, causing an increased strain 463 
on an already laboured cardiovascular system (33). Kong et al. (32) implemented 464 
cardiovascular- and strength-based exercise in an obese population and found significant 465 
improvements of systolic (-8%) and diastolic (-7%) blood pressure after 4 weeks of 22 h of 466 
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exercise per week in the hypoxic group. Notably, their hypoxic group participants completed 467 
6 h of the weekly training schedule (type of exercise session unknown) in a hypoxic 468 
environment, with the remainder carried out in normoxic conditions. Whereas, those who 469 
carried out all of the 22 h training load in normoxic conditions had less improvement in 470 
systolic (-3%) and diastolic (-1%) blood pressures. Compared to the normoxic group, 471 
Wiesner et al. (76) also reported a similar reduction in systolic (-2% versus -2%) but greater 472 
reduction in diastolic (-4% versus -1%) blood pressures in the hypoxic group over a similar 473 
duration of 4 weeks, yet with a reduced volume of exercise (180 min per week). All in all, 474 
active HC demonstrates more supportive evidence for improved blood pressure responses 475 
compared to active normoxic periods. That said, a previous review (62) concluded significant 476 
benefits to blood pressure values following active HC compared to normoxic conditions in 477 
those with various cardiovascular diseases, including normalisation and 3 month maintenance 478 
of stage 1 hypertensive patients (39). It could also be suggested that multiple combinations of 479 
exercise (cardiovascular and strength) carried out in hypoxic conditions are more beneficial 480 
than cardiovascular exercise alone to reduce blood pressure in obese populations. This is 481 
supported by the findings of Kong et al. (32), perhaps through enhanced vascular endothelial 482 
growth factor transcription leading to improved human vasculature control and capillary 483 
action (82). 484 
Reductions in heart rate, for a given exercise workload, have been observed for both 485 
hypoxic (-18%) and normoxic (-20%) groups post-intervention (32), yet only statistically 486 
significant in the normoxic group. In other studies, no change in heart rate during an exercise 487 
test before and after the intervention period was found in the hypoxic or normoxic group (46, 488 
76) – although lactate accumulation was reduced in both intervention groups (hypoxic: -11%, 489 
normoxic: -13% [76]). It could be suggested that due to obese humans having a lower 490 
baseline fitness level compared to athletic and healthy populations, it is likely that any form 491 
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of training will lead to an improved recovery response, via assessment of heart rate. 492 
Arguably, adding in an additional stimulus such as hypoxia likely reduces the potential of an 493 
increased recovery, and therefore, be less beneficial than the same workload in normoxic 494 
conditions. 495 
 Kong et al. (32) showed non-significant reductions in BMI (-6%) and weight (-7%) of 496 
the hypoxic group, however, obese humans in the normoxic group also showed non-497 
significant weight loss post-intervention (-4%). Netzer et al. (51) reported non-significant 498 
reductions in weight and BMI in the hypoxic group, however, this did not occur in the 499 
normoxic group. In another study, no change was found in BMI and fat mass following both 500 
the hypoxic (FiO2 = 15.0%) and normoxic intervention (moderate-intensity cycling, 3 times 501 
per week, 4 weeks), but the normoxic group did lose slightly more weight after the 502 
intervention compared to those in the hypoxic group (-1% versus -0.5%, respectively [46]). 503 
Overall, reductions in weight, BMI and individual tissue mass are found following active HC 504 
(moderate-intensity cardio-based exercise, 3 sessions per week, 4–8 week duration). This also 505 
occurs without hypoxia but to a lesser extent. Non-significant improvements in these studies 506 
may be strengthed if the small participant cohorts (~10 individuals per group) were increased 507 
to permit a greater effect size. Alternatively, it could be considered that participants became 508 
acclimatised to the hypoxic level (FiO2 = 15.0%), which was consistently maintained 509 
throughout the whole intervention period (4–8 weeks). This could have lead to a rapid plateau 510 
of adaptations in body composition as the absence of periodisation may not perpetuate 511 
beneficial gains. 512 
 513 
4.2.3. Combined passive and active hypoxic exposure 514 
 Gatterer et al. (18) employed a 90-min moderate intensity (65–70% HRmax) 515 
cardiovascular-based active HC (FiO2 = 14.0%) and a 90-min period of passive HC (FiO2 = 516 
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12.0%) twice per week, for 8 months in obese males and females. After 5 weeks, similar 517 
changes in both hypoxic and normoxic groups were reported for body weight (-2% and -1%) 518 
and fat mass (+1% and -1%). After 3 months, these responses were futher improved in 519 
comparison to the baseline assessment in the hypoxic (body weight: -4%, fat mass: -1%) as 520 
well as normoxic (body weight: -3%, fat mass: -2%) group. Additionally, similar reductions 521 
were found in both hypoxic and normoxic groups for values of systolic (-3% and -2%) and 522 
diastolic blood pressure (-3% and -3%). Following completion of the 8 month intervention 523 
period, those in the hypoxic group displayed reductions in fat mass (-1%) and blood pressure 524 
(systolic: -4%, diastolic: -2%). However, similar responses were found in the normoxic group 525 
(fat mass: -2%; systolic blood pressure: -6%; diastolic blood pressure: -5%). Interestingly, 526 
body weight was equally reduced in both groups (-3%) post-intervention. In the only 527 
available study, it seems that a combination of both passive and active HC has no added 528 
benefit compared to a matched workload in normoxic conditions on weight loss and cardio-529 
metabolic responses assessed here. The main explantion would be that unaltered stimuli (i.e., 530 
hypoxic level, exercise intensity/duration) throughout the intervention lead to a near plateau 531 
in most measures assessed over this 8 month period. 532 
 533 
5. Additional considerations  534 
At present, it is difficult to affirm that overall fitness is improved following active HC 535 
versus similar exercise training in normoxia of obese populations. Exercise performance in an 536 
obese population, assessed via total running distance over the course of a 4-week 537 
intervention, showed a tendency of being higher in the hypoxic compared to the normoxic 538 
group (+18% [32]). In contrast, workload during hypoxic in reference to normoxic sessions in 539 
other studies was typically lower (-17.5% [76], -20% [46]). When exercising in hypoxia, 540 
exercise may be perceived as ‘harder’ (majored internal load as evidenced by higher heart 541 
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rate, rating of perceived exertion or blood lactate values) versus a matched workload in 542 
normoxia, leading to a reduced total workload. Therefore, it may be that obese humans 543 
require multiple exercise modalities to continue exercising at a clamped intensity and 544 
complete a greater total workload.  545 
Cardiorespiratory fitness (VO2max) is a key determinant of morbidity and mortality 546 
(74). Following active HC (60-mins cardiovascular-based exercise, 55–65% VO2max, 3 times 547 
per week, for 4 weeks) non-significant increases in this determinant have been reported (46, 548 
76). However, these enhancements were visible in both the hypoxic and normoxic exercise 549 
groups (+5.6% versus +3.1% [76], +12.6% versus +8.7% [46]; hypoxia versus normoxia, 550 
respectively). Taken as a whole, this could indicate that the mode of exercise is primarily 551 
responsible for gains (i.e., not the addition of the hypoxic stimulus). Undoubtedly, detection 552 
of adaptations to the intervention is paramount to select training intensity, modality and 553 
duration for successful interventions in obese populations. One may argue that the studies 554 
included in the present review have primarily implemented exercise performance tests that 555 
are overly challenging for obese populations, due to the requirement of exercising to 556 
volitional exhaustion (46, 76). Other sea-level training studies of obese populations have 557 
incorporated a 10-m walk test (23), a 6-minute step test (5) and a 6-minute walk test (27) to 558 
assess post-intervention changes in aerobic exercise performance. To date, the inclusion of 559 
such performance tests is lacking in the field of HC. 560 
Other than one study which utilised a fixed SpO2 (77), all studies presented in this 561 
review have implemented a fixed FiO2 during exposure to hypoxia. One potential issue, 562 
however, is that the variance in individual response to a given simulated altitude is 563 
significant. In support of this, Hamlin et al. (22) concluded that for exposure to the same 564 
hypoxic level (FiO2 = 10.0%), there is a greater inter-individual variability in the extent of 565 
arterial desaturation compared to a clamped SpO2 of 75%. Additionally, obese humans are 566 
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considered as having a higher ‘resistance to hypoxia’ in comparison to healthy humans, and 567 
thereby a delayed/minimal desaturation (or SpO2 decrease) when exposed to low hypoxic 568 
doses (FiO2 12.0% [54]). To negate this, implementing fixed SpO2 values may minimise the 569 
number of ‘non-responding’ participants to a given hypoxic stimulus. Costalat et al. (8) 570 
recently investigated individualised intermittent passive exposure to hypoxia (SpO2 ~80%), 571 
including normoxia phases (re-oxygenation to ~95%), in overweight and obese individuals. 572 
However, this investigation was not included in this review due to a lack of a 573 
control/normoxic condition.  574 
 575 
6. Perspectives and significance 576 
Multiple reviews investigating the effects of reduced inspired O2 levels on those 577 
whom are obese and/or overweight have been published within the last decade. 578 
However, our paper is the first to highlight the beneficial effects of passive and active 579 
HC in both obese animals and humans on a variety of physiological, metabolic, 580 
hormonal and cardiovascular responses. These novel findings may be pivotal in 581 
improving the health and well being of these individuals. The rapid development of HC 582 
devices offers significant potential for real-world application as a therapeutic, cost-583 
effective and accessible treatment.    584 
 585 
7. Where next? 586 
Due to the consideration of HC as a treatment for obesity being relatively new, there 587 
are many avenues for future mechanistic and performance-led research to be conducted to 588 
improve cardio-metabolic health and promote weight loss.  589 
  590 
7.1. Exercise intensity 591 
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A number of studies in this review mention a reduced workload of participants 592 
carrying out moderate-intensity, continuous exercise in hypoxia compared to those in 593 
normoxia (46, 76), which has also been proposed elsewhere when clamping the metabolic 594 
demand (20). It would be interesting to investigate whether the cardio-metabolic responses of 595 
obese populations are significantly different between relative and absolute exercise intensities 596 
using direct comparisons (i.e., same participants), which may inform which exercise intensity 597 
is more suitable for setting training goals in this population. For example, cycling at 100 598 
watts in hypoxic conditions will create a greater physiological strain (increased heart rate, 599 
cardiac output) on the human body compared to the same absolute intensity in normoxic 600 
conditions; thus inducing a higher internal (physiological) load for a matched external (power 601 
output) load. When cycling at a similar relative intensity, the internal load most likely will be 602 
reduced during hypoxia to match the external load of exercising in normoxia, as 603 
demonstrated by Wiesner et al. (76). Further research of this area is required to validate this 604 
claim and differentiate the effect of adding hypoxia in comparison to the effect of exercising 605 
at different intensities. It could be that, clamping the metabolic demand (i.e., working at a 606 
given relative exercise intensity in hypoxia versus normoxia) may be beneficial for obese 607 
populations. Arguably, the muscoskeletal system load is likely reduced in O2-deprived 608 
environments and thereby could prevent further damage to joints, tendons and ligamets 609 
during locomotor activities (e.g., outdoor or treadmill walking). 610 
 In line with current American College of Sports Medicine (12) and UK National 611 
Health Service recommendations (49), the reviewed literature here suggests that a moderate-612 
intensity, continuous exercise training programme (60–75% HRmax for 60–90-min, 3 times 613 
per week) is the recommended method to achieve weight loss. However, a growing body of 614 
literature is indicating that implementation of high-intensity intermittent exercise (3–5 sets of 615 
high-intensity exercise periods at 75–95% HRmax for 2–5 min interspersed with shorter 616 
25 
 
recovery periods of 2–3 min) in obese populations is beneficial (19, 54, 75). Not only is this 617 
form of exercise more time- and metabolically-efficient (36), but also would be more 618 
beneficial for weight loss compared to moderate-intensity during normoxia (9, 60, 83). In 619 
prescribing such exercise,  a careful manipulation of work :rest ratios depending on the aim 620 
of the session (aerobically versus anaerobically-based responses) is needed.  621 
 622 
7.2. Psychological aspect of weight loss 623 
 A large, and often underestimated, factor in achieving weight loss is related to 624 
psychological behaviours. Exercising regularly requires motivation and enjoyment to 625 
maintain adherence (31). At present, pleasure-displeasure responses of healthy populations 626 
exercising at a high-intensity in normoxic conditions are varied with both positive affects 627 
(43) and negative moods (48) reported. To our knowledge, this type of investigation does not 628 
exist during and following HC of obese humans. Implementing such affect-perceptual 629 
measurements would significantly aid levels of adherence to achieve weight loss through 630 
long-term interventions. Interestingly, Ekkekakis & Linds (14) concluded that enjoyment 631 
was reduced when obese populations had an imposed exercise intensity 10% greater 632 
than a self-selected speed. It remains to be verified whether implementation of self-633 
selected speeds during shorter work periods in hypoxia would be more applicable in an 634 
obese population, as previously reported (14, 25). 635 
 636 
7.3. Differences within obese populations 637 
 Although this review is focused on the treatment of obese (BMI: 30–38 kg.m2) 638 
populations, some studies have been included with participant groups of overweight and 639 
sedentary animals and humans, with a large majority of evidence derived from obese animal 640 
findings. Further comparative research is warranted to investigate the responses of different 641 
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stages of obese populations (e.g., I, II and III [10]), males versus females, and young versus 642 
older populations with or without associated complications (i.e., pre-diabetes).  643 
 644 
7.4. Experimental considerations 645 
Finally, determining the extent of metabolic stress associated with HC for inducing 646 
clinically relevant (>3%) weight losses (66) should be a key focus area. Arguably, many 647 
confounding variables likely affect determination of the optimal dose-response during HC, 648 
such as food consumption, in the lead up to and following the completion of sessions. If these 649 
were to be controlled, and short-term (single session) cardio-metabolic responses were to be 650 
assessed in obese populations, it will be possible to implement the ‘optimal’ exposure 651 
protocol (i.e., most beneficial dose, duration and intensity) for long-term improvements in 652 
cardio-metabolic health and weight loss, as proposed recently by Serebrovskaya et al. (62). 653 
Additional consideration of potential drawbacks associated with HC, such as onset of 654 
obstructive sleep apnoea and acute mountain sickness, should be made to increase the 655 
possibility of developing optimal passive and active HC protocols. 656 
 657 
8. A summary of passive and active HC protocols  658 
Table 4 states a summary of passive and active HC protocols in relation to the 659 
literature presented in this review for improving cardio-metabolic health and 660 
promoting weight loss in obese humans. HC-induced physiological, metabolic, 661 
cardiovascular and hormonal responses are undoubtedly highly individual. 662 
Importantly, all of the animal models and human participant cohorts included here 663 
were free from associated cardio-metabolic complications. In reality, this may not 664 
always be the case. Therefore, we recommend full  general practitioner clearance to be 665 
obtained from prior to undertaking any HC, similar to the process of beginning any 666 
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physical activity programme/dietary intervention. Positive outcomes would also likely 667 
depend on the level of hypoxia employed and careful manipulation of key variables 668 
structuring the HC routine (e.g., number of cycles, duration, intensity, mode of exercise 669 
and/or periodisation). Importantly, this summary should be interpreted with caution 670 
and seenas a starting point only, as it is based upon the findings of a small amount of 671 
evidence (passive: 7 studies; active: 8 studies). We therefore encourage clinicians and 672 
researchers to refine them to reach a consensus. 673 
*Table 4 near here* 674 
 675 
9. Conclusions 676 
The findings of this review in obese populations suggest that a) passive HC could 677 
lead to reduced insulin concentrations (-37 – -22%) in animals and increased energy 678 
expenditure (+12 – +16%) in humans, while active HC may reduce body weight (-4 – -679 
2%) in both animals and humans as well as blood pressure (-8 – -3%) in humans; b) 680 
inconsistent findings and limited understanding still exist for determining the impact of acute 681 
and chronic HC on markers such as triglycerides, cholesterol levels and fitness capacity; and 682 
c) a large majority of studies include animal models exposed to severe levels of hypoxia 683 
(FiO2 = ~5.0%) that are not suitable for obese humans. Also, published findings, at present, 684 
do not clearly show changes in responses of heart rate, fat and muscle mass following HC 685 
being significantly larger than a matched exposure and/or exercise period in normoxic 686 
conditions. Nevertheless, the promising findings need larger cohorts, more mechanistic 687 
measures and real-world applications of findings to improve the potential clinical impact of 688 
this novel intervention. Finally, the industrial and technological advancement, including 689 
miniaturised equipment for home use and accessibility to environmental chambers, will 690 
certainly contribute to the expansion in the use of these methods.  691 
692 
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Table 1: Experimental details of studies included in this review that have investigated passive and active hypoxic conditioning.  961 
 Participants    Intervention 
Study Type Age Gender 
BMI 
(kg.m2) 
Groups 
Exposure 
type 
Approach Protocol Mode Duration 
Level of 
hypoxia 
(FiO2 %) 
Briancon-
Marjollet et al. 
(2016) 
Zucker rats 9 w 48 M NM 
Obese hypoxia (n = 
12) 
Passive N/a 
Intermittent (30 s :30 s) 8 
h.d 
N/a 2 w 
5.0 
Lean hypoxia (n = 12) 
Obese control (n = 12) 
N/a N/a 
Lean control (n = 12) 
Chen et al. 
(2011) 
Zucker rats 14 w 56 M NM 
Obese exercise (n = 7) 
Active 
LHTL 
90 mins daily exercise Swimming 
6 w 
N/a 
Lean exercise (n = 7) 
Obese hypoxia (n = 7) 
Passive Sustained 8 h.d N/a 14 
Lean hypoxia (n = 7) 
Obese exercise and 
hypoxia (n = 7) 
Active 
90 mins daily exercise 
sustained 8 h.d 
Swimming 20.9, 14.0 
Lean exercise and 
hypoxia (n = 7) 
Obese controls (n = 7) 
N/a N/a N/a N/a 
Lean controls (n = 7) 
Gatterer et al. 
(2015) 
Humans 51.4 y 
22 F, 10 
M 
37.1 
Hypoxia (n = 16) 
Combined LLTH 
90 mins moderate (65-
70% HRmax) intensity 
exercise, 90 mins rest 
Cycling, 
running, 
cross 
trainer 
2x w, 8 m 
14.0, 12.0 
Control (n = 16) N/a 
Kong et al. 
(2013) 
Humans 21.1 y 
8 F, 10 
M 
34.3 
Hypoxia (n = 10) 
Active LLTH 
Moderate (60-70% 
HRmax) intensity exercise, 
strength (40-50% 1 rep 
max, 3 sets of 15 reps, 2 – 
3 min rest periods) 
training 
Running, 
stepping, 
cycling, 
strength 
exercising 
22 h w, 4 
w 
15.0 
Control (n = 8) N/a 
Ling et al. 
(2008) 
Kunming mice NM 80 F NM 
Hypoxia-normal diet 
(n = 20) 
Passive N/a 
Intermittent (15 min :5 – 
10 min) 
N/a 8x d, 40 d 
14.3 
Hypoxia-fatty diet (n 
= 20) 
Control-normal diet (n 
= 20) 
N/a N/a 
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Control-fatty diet (n = 
20) 
Lu et al. 
(2014) 
Sprague Dawley rats 3 w 20 M NM 
Hypoxia (n = 10) Combined 
LHTH 
1 h exercise 6 d.w, lived 
in hypoxia 
Running 
4 w 
13.6 
Control (n = 10) N/a N/a N/a N/a 
Morishima et 
al. (2014) 
Humans 31y 20M NM 
Hypoxia (n = 9) 
Active LLTH 
60 mins moderate (55 % 
VO2max) intensity cycling 
Cycling 3x w, 4 w 
15.0 
Control (n = 11) N/a 
Netzer et al. 
(2008) 
Humans 47.8 y 
10 F, 22 
M 
33.1 
Hypoxia (n = 10) 
Active LLTH 
90 mins moderate (60% 
HRmax) exercise 
Stepping, 
running, 
cycling 
3x w, 8 w 
15.0 
Control (n = 10) N/a 
Olea et al. 
(2014) 
Wister rats 24 w 160 M NM 
Hypoxia obese (n = 
40) 
Passive 
N/a 
Intermittent (40s :80 s) 8  
h.d 
N/a 2 w 
5.0 
Hypoxia control (n = 
40) 
Obese (n = 40) 
N/a N/a N/a 
Control (n = 40) 
Polotsky et al. 
(2003) 
Mice NM 74 M NM 
Obese short-term 
hypoxia (n = 15) 
Passive 
N/a 
Intermittent (30 s :30 s) 
16 h.d 
N/a 
5 d 
4.8-5.0 
Lean short-term 
hypoxia (n = 16) 
Obese long-term 
hypoxia (n = 7) 
Intermittent (30 s:30 s) 12 
h.d 
12 w 
Lean short-term 
controls (n = 15) 
N/a 
 
N/a 5 d N/a Obese short-term 
controls (n = 14) 
Controls (n = 7) 
Rodriguez et 
al. (2014) 
Mice 10 w 82 M NM 
Obese hypoxia (n = 
10) Passive 
N/a 
Intermittent (30 s:30 s) 12  
h.d 
N/a 4 w 
5.0 
Lean hypoxia (n = 11) 
Obese controls (n = 
10) N/a N/a N/a 
Lean controls (n = 11) 
Obese hypoxia (n = 9) 
Passive Sustained 24 h.d 10 
Lean hypoxia (n = 10) 
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Obese controls (n = 
10) N/a N/a N/a 
Lean controls (n = 11) 
Wang et al. 
(2007) 
Humans 24 y 30 M 22.2 
Severe hypoxia (n = 
10) 
Passive 
N/a 
Sustained 1 h.d 
N/a 4 w 
12.0 
Moderate hypoxia (n 
= 10) 
15.0 
Control (n = 10) N/a N/a N/a 
Wiesner et al. 
(2009) 
Humans 42.2 y 
27 F, 18 
M 
30 
Hypoxia (n = 24) 
Active LLTH 
60 mins moderate (65% 
VO2max) intensity running 
Running 3x w, 4 w 
15.0 
Control (n = 21) N/a 
Workman & 
Basset (2012) 
Humans 28 y 15 M 27 
Acute hypoxia (n = 
11) 
Passive 
N/a 
Sustained 3 h 
N/a 
1d 
Target SpO2: 
80% Short-term hypoxia (n 
= 6) 
1x d, 1 w 
Control (n = 4) N/a N/a N/a N/a 
Wu et al. 
(2013) 
Zucker rats 14 w 56 M NM 
Obese exercise (n = 7) 
Active 
LHTL 
90 mins daily swimming Swimming 
6 w 
N/a 
Lean exercise (n = 7) 
Obese hypoxia (n = 7) 
Passive Sustained 8 h.d N/a 14 
Lean hypoxia (n = 7) 
Obese exercise and 
hypoxia (n = 7) 
Active 
90 mins daily swimming, 
sustained 8 h.d 
Swimming 20.9, 14.0 
Lean exercise and 
hypoxia (n = 7) 
Obese controls (n = 7) 
N/a N/a N/a N/a 
Lean controls (n = 7) 
BMI = body mass index; d = day(s); F = female(s); FiO2 = fraction of inspired oxygen; h = hour(s); HRmax = heart rate maximum; LHTH = 
live-high train-high; LHTL = live-high train-low; LLTH = live-low train-high; M = male(s); mins = minutes; m = months; n = number; N/a = 
not applicable; NM = not measured; rep max = repetition maximum; s = seconds; VO2max = maximal oxygen uptake; w = week(s); y = years. 
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Table 2: A summary of the findings for animal studies included in this review.  962 
  Measures          
Study Condition Glucose Insulin Cholesterol HDL LDL Triglycerides Leptin BP Body weight 
Briancon-
Marjollet et al. 
(2016) 
Obese hypoxia          
Lean hypoxia          
Obese control          
Lean control          
Chen et al. 
(2011) 
Obese exercise          
Obese exercise and hypoxia          
Obese controls          
Ling et al. 
(2008) 
Hypoxia-normal diet  
        
Hypoxia-fatty diet          
Control-normal diet          
Control-fatty diet          
Lu et al. 
(2014) 
Hypoxia          
Control          
Olea et al. 
(2014) 
Hypoxia obese          
Hypoxia control          
Obese          
Control          
Polotsky et al. 
(2003) 
Obese short-term hypoxia          
Lean short-term hypoxia          
Obese long-term hypoxia          
Lean short-term control          
Obese short-term control          
Control          
Rodriguez et 
al. (2014) 
Obese hypoxia          
Lean hypoxia          
Wu et al. 
(2013) 
Obese exercise          
Obese exercise and hypoxia          
Obese control          
BP = blood pressure; HDL = high-density lipoprotein cholesterol; LDL = low-density lipoprotein cholesterol;  = 
increase;  = decrease;  = maintenance. 
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Table 3: A summary of the findings for human studies included in this review.  964 
  Measures 
Study Condition Glucose Insulin Cholesterol HDL Triglycerides EE Lipid metabolism Glycogen metabolism HR BP La
+ BMI Body weight 
Gatterer et al. 
(2015) 
Hypoxia 
             
Control              
Kong et al. 
(2013) 
Hypoxia              
Control 
             
Morishima et 
al. (2014) 
Hypoxia 
             
Control 
             
Netzer et al. 
(2008) 
Hypoxia 
             
Wang et al. 
(2007) 
Severe hypoxa 
             
Wiesner et al. 
(2009) 
Hypoxia              
Control              
Workman & 
Basset (2012) 
Acute hypoxia              
Short-term hypoxia              
BMI = body mass index; BP = blood pressure; EE = energy expenditure; HDL = high-density lipoprotein cholesterol; HR = heart rate; La
+
 = 
lactate accumulation;  = increase;  = decrease;  = maintenance. 
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Table 4: A summary of the passive and active hypoxic conditioning protocols for 966 
improving cardio-metabolic health and promoting weight loss of overweight or obese 967 
humans, based on the evidence presented in this review.  968 
 Type of exposure 
Variable Passive Active 
Level of hypoxia (FiO2 %) 10.0–12.0 13.0–14.0 
Number of cycles 5–15 N/a 
Intensity N/a 55–65% VO2max / 60–70% HRmax 
Duration (hours) 1–1.5 1–1.5 
Frequency Daily 2–3 times per week 
Periodisation (weeks) 2–4 4–6 
FiO2 = fraction of inspired oxygen; HR = heart rate; N/a = 
not applicable; VO2max = maximal oxygen uptake. 
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